Zhejiang Shouxiangu Botanical Drug Institute

Zhejiang Shouxiangu Botanical Drug Institute is the dedicated research and development subsidiary of Zhejiang Shouxiangu Pharmaceutical, a prominent Chinese company specializing in Traditional Chinese Medicine (TCM). The institute focuses on the scientific modernization of botanical drugs, particularly through the optimization of Ganoderma lucidum (Lingzhi) and Dendrobium officinale. Its core activities include germplasm preservation, precision breeding, and the development of advanced processing techniques such as wall-breaking technology for spores to enhance bioavailability. The institute operates a comprehensive whole-chain R&D platform that ensures standardized quality from the selection of seeds to clinical validation. Its products are primarily positioned for immune system support, oncology adjuvant therapy, and chronic disease prevention.